1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. KIROMIC BIOPHARMA INC
Kiromic BioPharma Inc XNAS: KRBP

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Kiromic BioPharma Inc is on 17 Jul 2025 for the purpose of Kiromic BioPharma Inc Annual General Meeting for 2025 See details


Insider Trading disclosures for Kiromic BioPharma Inc

The latest disclosure was made by Pietro Bersani in Kiromic BioPharma Inc where a trade of 2,500 Common Stock done at an average price of $2.2 was reported to US exchanges on Aug. 23, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pietro Bersani Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.20 per share. 23 Aug 2024 2,500 141,345 - 2.2 5,500 Common Stock
Pietro Bersani Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.93 per share. 23 Aug 2024 988 142,333 - 1.9 1,907 Common Stock
Brian Hungerford Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.25 per share. 19 Aug 2024 258 61,191 - 2.3 581 Common Stock
Brian Hungerford Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.20 per share. 19 Aug 2024 3,742 64,933 - 2.2 8,221 Common Stock
Brian Hungerford Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.75 per share. 13 Aug 2024 2,000 60,933 - 1.8 3,500 Common Stock
Brian Hungerford CFO Purchase of securities on an exchange or from another person at price $ 2.60 per share. 13 Jun 2024 1,000 58,933 - 2.6 2,600 Common Stock
Pam Misajon Director Purchase of securities on an exchange or from another person at price $ 3.24 per share. 12 Jun 2024 410 28,811 - 3.2 1,328 Common Stock
Pam Misajon Director Purchase of securities on an exchange or from another person at price $ 3.30 per share. 12 Jun 2024 1,200 28,401 - 3.3 3,960 Common Stock
Brian Hungerford CFO Purchase of securities on an exchange or from another person at price $ 3.18 per share. 12 Jun 2024 1,000 57,933 - 3.2 3,180 Common Stock
Pietro Bersani Director, CEO Purchase of securities on an exchange or from another person at price $ 3.23 per share. 11 Jun 2024 3,000 135,845 - 3.2 9,690 Common Stock
Pietro Bersani Director, CEO Purchase of securities on an exchange or from another person at price $ 3.28 per share. 11 Jun 2024 3,000 138,845 - 3.3 9,840 Common Stock
Michael Nagel Director Purchase of securities on an exchange or from another person at price $ 3.33 per share. 11 Jun 2024 1,000 43,296 - 3.3 3,330 Common Stock
Pam Misajon Director Purchase of securities on an exchange or from another person at price $ 2.93 per share. 10 Jun 2024 1,701 27,201 - 2.9 4,984 Common Stock
Brian Hungerford CFO Other type of transaction at price $ 0.00 per share. 03 May 2024 21,900 0 - - Restricted Stock Units
Brian Hungerford CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 21,900 56,933 - 0 Restricted Stock Award
Brian Hungerford CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 35,033 35,033 - 0 Restricted Stock Award
Pietro Bersani Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 45,968 45,968 - 0 Restricted Stock Award
Mike Catlin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2024 18,000 25,500 - - Restricted Stock Award
Pam Misajon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2024 18,000 25,500 - - Restricted Stock Award
Michael Nagel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2024 18,000 42,296 - - Restricted Stock Award
Daniel Clark Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2022 50,000 62,770 - 0 Common Stock
Pietro Bersani Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2022 638,298 638,298 - 0 Common Stock
Scott Dahlbeck Chief of Staff Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2022 50,000 496,757 - 0 Common Stock
Francis X. Tirelli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 183,600 183,600 - - Stock Option (Right to Buy)
Americo Cicchetti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 183,600 188,878 - - Stock Option (Right to Buy)
Karen Reeves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 183,600 183,600 - - Stock Option (Right to Buy)
Michael Nagel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2022 183,600 188,878 - - Stock Option (Right to Buy)
Scott Dahlbeck Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 May 2022 17,240 446,757 - - Common Stock
Scott Dahlbeck Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 May 2022 17,240 0 - - Restricted Stock Units
Maurizio Chiriva Internati Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.70 per share. 09 Sep 2021 2,800 1,378,072 - 3.7 10,357 Common Stock
Michael Charles Ryan See Remarks Other type of transaction at price $ 0.00 per share. 12 Jul 2021 31,991 31,991 - - Restricted Stock Units
Michael Charles Ryan See Remarks Other type of transaction at price $ 0.00 per share. 12 Jul 2021 50,189 50,189 - 0 Common Stock
Ignacio Nunez CHIEF OPERAT. AND MANUF. OFFI. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2021 147,038 147,038 - - Employee Stock Option (right to buy)
Ignacio Nunez CHIEF OPERAT. AND MANUF. OFFI. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2021 17,710 17,710 - - Restricted Stock Units
Gianluca Rotino Director, CHIEF STRAT & INNOV OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2021 71,985 280,076 - - Restricted Stock Units
Jerry A. Schneider Director Purchase of securities on an exchange or from another person at price $ 7.31 per share. 24 May 2021 5,000 5,000 - 7.3 36,550 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters